References
  1. Yadav SP. COVID-19 in Children with Blood and Cancer Disorders: What Do We Know So Far? J Pediatr Hematol Oncol . 2020;42(6):413-414. doi:10.1097/MPH.0000000000001872
  2. Boulad F, Kamboj M, Bouvier N, Maureen A, Kung AL. COVID-19 in Children with Cancer in New York City. JAMA Oncology . doi:10.1001/jamaoncol.2020.2028.
  3. To KK, Hung IF, Ip JD, Chu AW, Chan W, Tam AR et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clinical Infectious Diseases , ciaa1275, https://doi.org/10.1093/cid/ciaa1275
  4. Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature 2020;584:450-456. https://doi.org/10.1038/s41586-020-2571-7
  5. Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JCC, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. bioRxiv 2020;doi:  https://doi.org/10.1101/2020.07.21.214759